56876-58-5 Usage
Chemical class
Thiochroman compounds
Explanation
The compound belongs to the class of thiochroman compounds, which are bicyclic compounds with a thiophene ring fused to a chromane ring.
Explanation
The compound consists of a butane-1,2-dione moiety (a four-carbon chain with two carbonyl groups) connected to a 4-oxothiochroman-3-yl group (a thiochroman with an additional carbonyl group at the 4-position).
Explanation
Thiochromans have been studied for their various biological activities, which may lead to potential applications in the pharmaceutical industry.
Explanation
Thiochroman compounds, in general, have been investigated for their anticancer, anti-inflammatory, and anti-fungal properties, which could be relevant for the compound in question.
Explanation
The specific properties and uses of 1-(4-oxothiochroman-3-yl)butane-1,2-dione would need to be further investigated through research and testing to determine its potential applications and effectiveness.
Explanation
The molecular formula represents the number of carbon (C), hydrogen (H), oxygen (O), and sulfur (S) atoms in the compound.
Explanation
The molecular weight is the sum of the atomic weights of all the atoms in the molecule, which is approximately 232.26 grams per mole for 1-(4-oxothiochroman-3-yl)butane-1,2-dione.
Explanation
Based on its molecular weight and structure, 1-(4-oxothiochroman-3-yl)butane-1,2-dione is likely to be a solid or crystalline substance at room temperature.
Explanation
The solubility of the compound is not provided, but it may be soluble in organic solvents like ethanol, methanol, or acetone due to its nonpolar nature.
Explanation
The stability of the compound is not provided, but it may be sensitive to factors such as light, heat, or moisture, which could affect its shelf life and storage conditions.
Structure
Butane-1,2-dione moiety attached to a 4-oxothiochroman-3-yl group
Potential applications
Pharmaceuticals
Biological activities
Anticancer, anti-inflammatory, and anti-fungal properties
Further research needed
Specific properties and uses
Molecular weight
Approximately 232.26 g/mol
Appearance
Likely a solid or crystalline substance
Solubility
Unknown, but potentially soluble in organic solvents
Stability
Unknown, but may be sensitive to light, heat, or moisture
Check Digit Verification of cas no
The CAS Registry Mumber 56876-58-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,6,8,7 and 6 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 56876-58:
(7*5)+(6*6)+(5*8)+(4*7)+(3*6)+(2*5)+(1*8)=175
175 % 10 = 5
So 56876-58-5 is a valid CAS Registry Number.
56876-58-5Relevant academic research and scientific papers
Synthesis, characterization, antimicrobial, anticancer, and antituberculosis activity of some new pyrazole, isoxazole, pyrimidine and benzodiazepine derivatives containing thiochromeno and benzothiepino moieties
Palanisamy, Pandaram,Jenniefer, Samson Jegan,Muthiah, Packianathan Thomas,Kumaresan, Sudalaiandi
, p. 19300 - 19310 (2013/10/22)
In an attempt to find a new class of antimicrobial, anticancer, and antituberculosis agents, a series of pyrazole, isoxazole, pyrimidine and benzodiazepine derivatives containing thiochromeno and benzothiepino moieties were prepared via the reaction of diketoester 2 and 11 with appropriate chemical reagents. Single crystal XRD studies have been done on compounds 3 and 12. All compounds were evaluated for antimicrobial, anticancer, and antituberculosis activity. The benzodiazepine compounds (9 and 18) displayed the highest activity among the tested compounds with an IC50 equal to 15 and 16 μM for HeLa cells, and 13 and 12 μM for HCT116 cells. They were also found to be more active against H37Rv with an MIC of 7.0 and 6.5 μM compared to other analogues. Similarly these compounds (9 and 18) showed higher activity than chloroamphenicol against Klebsiella pneumoniae and Escherichia coli.
TRICYCLIC PYRAZOL AMINE DERIVATIVES
-
Page/Page column 129, (2011/06/16)
This invention relates to compounds of Formula (I*) as Pi3k inhibitors for treating autoimmune diseases, inflammatory disorders, multiple sclerosis and other diseases like cancers.